UCL Institute of Ophthalmology

We are seeking two part-time Research Assistants to join a research group lead by Professor Mariya Moosajee, @profmariya.bsky.social, focused on understanding ocular development and genetic diseases of the eye. Deadline to apply is 23 March. www.ucl.ac.uk/work-at-ucl/...

It's #WorldGlaucomaWeek: an opportunity to be reminded about the importance of regular eye checks as first line of prevention. While #glaucoma continues to be a leading cause of blindness globally, ongoing research and advancements in treatment are enhancing patient outcomes.

#GlaucomaAwareness

Usher Syndrome Information Day 2026 Join us in person for Usher Syndrome Info Day 2026 to learn, share, and connect with the community!

We are hosting an #UsherSyndrome Patient #Information Day on Sat 21st March in London with @moorfieldsbrc.bsky.social.

Its free and will be hugely informative to those touched by this rare condition. Please register to attend using this link👉🏼 www.eventbrite.com/e/usher-synd...

Research Assistant in Ocular Cell Biology position closes on 25 February. This would suit an ambitious graduate with a background in the mechanisms of repeat expansion biology, neurodegeneration, and human disease models. www.ucl.ac.uk/work-at-ucl/...

Immersive event to celebrate 200 years of chemistry at UCL Experiments from the Victoria era will be recreated in the Bloomsbury Theatre at an event celebrating 200 years of chemistry at UCL.

Come to Bloomsbury Theatre to celebrate 200 years of UCL Chemistry! This immersive event will feature talks, short films, and the re-creation of Victorian-era experiments @uclchemistry.bsky.social. Tickets: www.bloomsburytheatre.com/event/2026/0...

We are seeking a Research Assistant in Ocular Cell Biolog. The position would suit an ambitious graduate with a background in the mechanisms of repeat expansion biology, neurodegeneration, and human disease models. Closes 25 February. lnkd.in/exsVf68y

Today, UCL marks 200 years since its foundation.
This year, we'll celebrate two centuries of learning and innovation and share those achievements with our community.

Discover our Faculty's exciting #UCL200 programme of events and learn how you can get involved: www.ucl.ac.uk/brain-scienc...

📺"What is now an institution in the top 10 elite list of universities started off as an up-start"

BBC London report on @ucl.ac.uk's 200th anniversary, featuring Prof @profginab.bsky.social @ioe.bsky.social and UCL President & Provost, Dr Michael Spence.

Happy 200th birthday, UCL! Today marks 200 years since UCL was founded, London's very first university. We are very proud to be part of its rich and diverse community of scientists, students and researchers. #UCL200

Happy International Day of Women and Girls in Science! Thank you to the brilliant ladies in my research lab @ucleye.bsky.social @moorfieldsbrc.bsky.social who make such a difference to vision research #WomeninScience @anarod7.bsky.social Dr Nicky Cronbach, Dr Randa Li 💙

Today, UCL turns 200. 🎉 For two centuries, our community has opened doors, challenged convention and pushed the boundaries of knowledge across every discipline. Thank you to everyone who’s been part of the UCL story, here’s to the next century. ✨

#UCL200 #LoveUCL

Your Eyes Are Revealing Diseases Hiding in Your Body YouTube video by Mork Unfiltered

CEO mentor, author and podcaster Patrick Mork invites INSIGHT director @pearsekeane.bsky.social to share how he built a career in #ophthalmology and helped to forge the fields of artificial medical intelligence and #oculomics at @ucleye.bsky.social and Moorfields Eye Hospital.

youtu.be/ppuGE7_Nzp8

👁️As we mark #GlaucomaAwarenessMonth, new research in BJO shows glaucoma cases in the UK are higher than previously thought and could rise to over 1.6m by 2060.

The study highlights the importance of earlier detection and service innovation.

Read more: moorfieldsbrc.nihr.ac.uk/uk-glaucoma-...

Current burden and future projections of glaucoma in the United Kingdom Background/aims Up-to-date, stratified estimates of the number of individuals affected by glaucoma in the UK are lacking. This study aimed to estimate the current and future glaucoma burden in the UK ...

One million people in the UK have glaucoma, the commonest cause of irreversible blindness. While this fate afflicts 10% of sufferers in their lifetime, 50% of people in the UK living with glaucoma don't know they have it @ucleye.bsky.social @moorfieldsbrc.bsky.social
bjo.bmj.com/content/earl...

Over 1 million estimated to have glaucoma in UK Over one million people are estimated to currently have glaucoma in the UK, a figure projected to reach more than 1.6 million by 2060, according to a study led by UCL and Moorfields researchers.

Over 1 million people are estimated to currently have glaucoma in the UK, a figure projected to reach more than 1.6 million by 2060, largely due to the ageing population, according to a study led by Prof Paul Foster @ucleye.bsky.social @moorfieldsbrc.bsky.social

World-first project shows great promise to treat low eye pressure A new study demonstrates the effectiveness of a widely-used eye injection to manage the previously untreatable rare condition, hypotony, in a project by clinical researchers at UCL and Moorfields Eye ...

A new study demonstrates the effectiveness of a widely-used eye injection to manage the previously untreatable rare condition, hypotony, in a project by clinical researchers at @ucleye.bsky.social and Moorfields Eye Hospital.
www.ucl.ac.uk/news/2026/ja...

We are so proud of our students and their innovative thinking. Read about what some of them accomplished this year. www.ucl.ac.uk/brain-scienc...

As 2025 draws to a close, join us in reflecting on some of the incredible breakthroughs from the Faculty this year!
👁️ In February, a procedure developed by researchers from @ucleye.bsky.social gave infants life-changing improvements in sight.
www.ucl.ac.uk/news/2025/fe...

We are happy to launch our latest Annual Review, highlighting our achievements during the 2024-2025 academic year. You can access the full content on our website: www.ucl.ac.uk/brain-scienc...

We are seeking a Combined Part-time PhD / Research Assistant in AI Higher Education, a unique opportunity to combine a p/t PhD fellowship with a paid 0.5 FTE Research Assistant post. Closing date in 4 days! (16 December).
www.ucl.ac.uk/work-at-ucl/...

🧵/ November was packed with breakthroughs and stories from UCL Faculty of Brain Sciences! Here’s your monthly roundup of research, awards, and achievements 👇
@uclpals.bsky.social @uclpsychiatry.bsky.social @uclqsion.bsky.social @ucleye.bsky.social

Using retinal images to predict disease across the world Senior Research Fellow Dr Yukun Zhou (UCL Institute of Ophthalmology) – a Wellcome Early-Career Award recipient – is using AI and eye imagery to develop early screening for an array of diseases.

Senior Research Fellow Dr Yukun Zhou (@ucleye.bsky.social, @insighteyehub.bsky.social and @uclbrainscience.bsky.social) is using AI and eye imagery to develop early screening for a range of diseases – supported by a @wellcometrust.bsky.social Early-Career Award ⬇

#UCLandChina

#UCLHealth

👩🔬 Meet Dr @giuliaderossi.bsky.social, Senior Research Fellow at @ucleye.bsky.social.
She speaks to us about her career highlights and why it's such an exciting time to work in the field of Ophthalmology.
👉 www.ucl.ac.uk/brain-scienc...

Transforming UK eye health research by linking national data resources The world’s largest collection of curated eye imaging and linked clinical data is expanding across the country, in an initiative led out of Moorfields Eye Hospital NHS Foundation Trust and UCL.

The world’s largest collection of curated eye imaging and linked clinical data is expanding across the country, in an initiative led out of Moorfields Eye Hospital NHS Foundation Trust and @ucleye.bsky.social.

Early trigger of diabetic eye disease identified A team led by UCL scientists has identified a key protein that triggers diabetic retinopathy – a condition caused by high blood sugar damaging the retina’s blood vessels and a leading cause of sight…

A team led by @ucleye.bsky.social scientists has identified a key protein that triggers diabetic retinopathy – a condition caused by high blood sugar damaging the retina’s blood vessels and a leading cause of sight loss among working-age adults.

AI can identify treatment gaps for patients with macular disease, study shows Using artificial intelligence (AI) in eye clinics could reduce both undertreatment and overtreatment of neovascular or ‘wet’ age-related macular degeneration (AMD)

An AI system can identify patients who are being under-treated or over-treated for sight-threatening macular disease. Validated at two UK eye centres, the AI could help transform NHS monitoring.

Work led by Jeffry Hogg and pearsekeane at @ucleye.bsky.social @moorfieldsbrc.bsky.social
bit.ly/4nsYO5O

UCL – University College London UCL is consistently ranked as one of the top ten universities in the world (QS World University Rankings 2010-2022) and is No.2 in the UK for research power (Research Excellence Framework 2021).

We are seeking a Research Programme Manager to work with Professor Anthony Khawaja to provide strategic, operational, and technical management and administrative support across a wide research programme for our @moorfieldsbrc.bsky.social. Closes: 3 November. www.ucl.ac.uk/work-at-ucl/...

None of this would have been possible without the generous support of @diabetesuk.bsky.social, #moorfieldseyecharity, @ucltro.bsky.social and @wellcometrust.bsky.social 🙏

Also very grateful to
@ucleye.bsky.social
for being such an inspiring and supportive place to do science. 🧪

Early trigger of diabetic eye disease identified A team led by UCL scientists has identified a key protein that triggers diabetic retinopathy – a condition caused by high blood sugar damaging the retina’s blood vessels and a leading cause of sight l...

A team led by Dr @giuliaderossi.bsky.social @ucleye.bsky.social has identified a key protein that triggers diabetic retinopathy – a leading cause of sight loss among working-age adults – in a finding that has the potential to revolutionise how the disease is treated